123 related articles for article (PubMed ID: 26344721)
1. Calnexin is a novel sero-diagnostic marker for lung cancer.
Kobayashi M; Nagashio R; Jiang SX; Saito K; Tsuchiya B; Ryuge S; Katono K; Nakashima H; Fukuda E; Goshima N; Satoh Y; Masuda N; Saegusa M; Sato Y
Lung Cancer; 2015 Nov; 90(2):342-5. PubMed ID: 26344721
[TBL] [Abstract][Full Text] [Related]
2. CAXII Is a sero-diagnostic marker for lung cancer.
Kobayashi M; Matsumoto T; Ryuge S; Yanagita K; Nagashio R; Kawakami Y; Goshima N; Jiang SX; Saegusa M; Iyoda A; Satoh Y; Masuda N; Sato Y
PLoS One; 2012; 7(3):e33952. PubMed ID: 22439015
[TBL] [Abstract][Full Text] [Related]
3. Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas.
Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Shinichiro R; Masuda N; Goshima N; Jiang SX; Okayasu I
Lung Cancer; 2010 Jul; 69(1):54-9. PubMed ID: 19892429
[TBL] [Abstract][Full Text] [Related]
4. Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung Cancer.
Yanagita K; Nagashio R; Jiang SX; Kuchitsu Y; Hachimura K; Ichinoe M; Igawa S; Fukuda E; Goshima N; Satoh Y; Murakumo Y; Saegusa M; Sato Y
Am J Pathol; 2018 Jun; 188(6):1328-1333. PubMed ID: 29751934
[TBL] [Abstract][Full Text] [Related]
5. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93.
Shitara K; Hanai N; Yoshida H
Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444
[TBL] [Abstract][Full Text] [Related]
6. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
[TBL] [Abstract][Full Text] [Related]
7. Generation of human monoclonal antibodies recognising membranous antigens of the lung adenocarcinoma cell line A549 using an AMeX immunohistostaining method.
Yoshinari K; Kimura H; Arai K; Sugawara I; Noda K; Kihara M; Misaki H; Yamaguchi Y
Br J Cancer; 1996 Aug; 74(3):359-67. PubMed ID: 8695349
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of useful sero-diagnostic autoantibodies using the same patients'sera and tumor tissues.
Kobayashi M; Nagashio R; Ryuge S; Murakami Y; Yanagita K; Nakashima H; Matsumoto T; Jiang SX; Saegusa M; Satoh Y; Masuda N; Sato Y
Biomed Res; 2014; 35(2):133-43. PubMed ID: 24759181
[TBL] [Abstract][Full Text] [Related]
9. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.
Madoz-Gúrpide J; Kuick R; Wang H; Misek DE; Hanash SM
Mol Cell Proteomics; 2008 Feb; 7(2):268-81. PubMed ID: 17916591
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal antibodies to lung cancer antigens (a review of the literature)].
Tkacheva GA
Med Radiol (Mosk); 1989 May; 34(5):62-75. PubMed ID: 2542715
[No Abstract] [Full Text] [Related]
11. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
Szpak CA; Johnston WW; Roggli V; Kolbeck J; Lottich SC; Vollmer R; Thor A; Schlom J
Am J Pathol; 1986 Feb; 122(2):252-60. PubMed ID: 2418688
[TBL] [Abstract][Full Text] [Related]
14. Application of anti lung adenocarcinoma monoclonal antibody recognizing cytokeratin-like cytoplasmic antigen for tumor diagnosis.
Shitara K; Fujiwara K; Kusano A; Yamaguchi K; Yoshida H; Sato S; Hanai N
Anticancer Res; 1992; 12(4):1121-9. PubMed ID: 1503402
[TBL] [Abstract][Full Text] [Related]
15. [Possibilities of early diagnosis of tumors].
Sarkisian GP; Bulycheva TI; Karagiulian SR; Tochenov AV; Shavlokhov VS
Ter Arkh; 2005; 77(4):33-7. PubMed ID: 15938530
[TBL] [Abstract][Full Text] [Related]
16. A 6-antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma.
Tacha D; Yu C; Bremer R; Qi W; Haas T
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):201-7. PubMed ID: 22498669
[TBL] [Abstract][Full Text] [Related]
17. A novel monoclonal antibody-defined antigen which distinguishes human non-small cell from small cell lung carcinomas.
Sobol RE; Peters RE; Astarita RW; Hofeditz C; Masui H; Burton D; Handley HH; Glassy MC; Fairshter R; Carlo DJ
Cancer Res; 1986 Sep; 46(9):4746-50. PubMed ID: 3015395
[TBL] [Abstract][Full Text] [Related]
18. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
Pereira-Faca SR; Kuick R; Puravs E; Zhang Q; Krasnoselsky AL; Phanstiel D; Qiu J; Misek DE; Hinderer R; Tammemagi M; Landi MT; Caporaso N; Pfeiffer R; Edelstein C; Goodman G; Barnett M; Thornquist M; Brenner D; Hanash SM
Cancer Res; 2007 Dec; 67(24):12000-6. PubMed ID: 18089831
[TBL] [Abstract][Full Text] [Related]
19. The 14-3-3 protein as the antigen for lung cancer-associated human monoclonal antibody AE6F4.
Shoji M; Kawamoto S; Setoguchi Y; Mochizuki K; Honjoh T; Kato M; Hashizume S; Hanagiri T; Yoshimatsu T; Nakanishi K
Hum Antibodies Hybridomas; 1994; 5(3-4):123-30. PubMed ID: 7756577
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
